RADNET INC (RDNT) Stock Fundamental Analysis
NASDAQ:RDNT - Nasdaq - US7504911022 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to RDNT. RDNT was compared to 103 industry peers in the Health Care Providers & Services industry. RDNT has only an average score on both its financial health and profitability. While showing a medium growth rate, RDNT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
RDNT had positive earnings in the past year.
In the past year RDNT had a positive cash flow from operations.
RDNT had positive earnings in 4 of the past 5 years.
RDNT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of RDNT (-0.97%) is comparable to the rest of the industry.
RDNT has a Return On Equity of -3.60%. This is comparable to the rest of the industry: RDNT outperforms 48.54% of its industry peers.
RDNT has a Return On Invested Capital (2.38%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for RDNT is significantly below the industry average of 9.38%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.97% | ||
| ROE | -3.6% | ||
| ROIC | 2.38% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
1.3 Margins
RDNT's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 4.38%, RDNT is in line with its industry, outperforming 58.25% of the companies in the same industry.
RDNT's Operating Margin has been stable in the last couple of years.
The Gross Margin of RDNT (22.61%) is comparable to the rest of the industry.
RDNT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.38% | ||
| PM (TTM) | N/A | ||
| GM | 22.61% |
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
RDNT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
RDNT has about the same amout of shares outstanding than it did 1 year ago.
RDNT has more shares outstanding than it did 5 years ago.
RDNT has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.78, we must say that RDNT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.78, RDNT is in line with its industry, outperforming 44.66% of the companies in the same industry.
RDNT has a debt to FCF ratio of 12.96. This is a negative value and a sign of low solvency as RDNT would need 12.96 years to pay back of all of its debts.
With a Debt to FCF ratio value of 12.96, RDNT perfoms like the industry average, outperforming 44.66% of the companies in the same industry.
RDNT has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.10, RDNT is not doing good in the industry: 64.08% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.1 | ||
| Debt/FCF | 12.96 | ||
| Altman-Z | 1.78 |
ROIC/WACC0.26
WACC9.31%
2.3 Liquidity
RDNT has a Current Ratio of 2.01. This indicates that RDNT is financially healthy and has no problem in meeting its short term obligations.
RDNT has a better Current ratio (2.01) than 72.82% of its industry peers.
A Quick Ratio of 2.01 indicates that RDNT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.01, RDNT is in the better half of the industry, outperforming 74.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.01 | ||
| Quick Ratio | 2.01 |
3. Growth
3.1 Past
The earnings per share for RDNT have decreased strongly by -67.69% in the last year.
The Earnings Per Share has been growing by 16.79% on average over the past years. This is quite good.
Looking at the last year, RDNT shows a quite strong growth in Revenue. The Revenue has grown by 12.76% in the last year.
Measured over the past years, RDNT shows a quite strong growth in Revenue. The Revenue has been growing by 9.65% on average per year.
EPS 1Y (TTM)-67.69%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%-600%
Revenue 1Y (TTM)12.76%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%9.19%
3.2 Future
RDNT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.09% yearly.
Based on estimates for the next years, RDNT will show a quite strong growth in Revenue. The Revenue will grow by 8.17% on average per year.
EPS Next Y-62.53%
EPS Next 2Y8.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.99%
Revenue Next 2Y8.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
RDNT is valuated quite expensively with a Price/Earnings ratio of 250.14.
Based on the Price/Earnings ratio, RDNT is valued a bit more expensive than the industry average as 60.19% of the companies are valued more cheaply.
RDNT is valuated expensively when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 71.36, RDNT can be considered very expensive at the moment.
RDNT's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 35.28. RDNT is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 250.14 | ||
| Fwd PE | 71.36 |
4.2 Price Multiples
RDNT's Enterprise Value to EBITDA is on the same level as the industry average.
RDNT's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 51.83 | ||
| EV/EBITDA | 15.41 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)14.9
EPS Next 2Y8.09%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for RDNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
52.53
-0.43 (-0.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners93.09%
Inst Owner Change0.21%
Ins Owners13.48%
Ins Owner Change-0.4%
Market Cap4.04B
Analysts86.15
Price Target73 (38.97%)
Short Float %9.7%
Short Ratio10.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-77.8%
Min EPS beat(2)-161.6%
Max EPS beat(2)5.99%
EPS beat(4)2
Avg EPS beat(4)-35.08%
Min EPS beat(4)-161.6%
Max EPS beat(4)20.87%
EPS beat(8)6
Avg EPS beat(8)178.25%
EPS beat(12)7
Avg EPS beat(12)117.98%
EPS beat(16)9
Avg EPS beat(16)-190%
Revenue beat(2)2
Avg Revenue beat(2)2.78%
Min Revenue beat(2)1.29%
Max Revenue beat(2)4.27%
Revenue beat(4)4
Avg Revenue beat(4)2.9%
Min Revenue beat(4)1.29%
Max Revenue beat(4)4.27%
Revenue beat(8)8
Avg Revenue beat(8)1.8%
Revenue beat(12)10
Avg Revenue beat(12)1.98%
Revenue beat(16)12
Avg Revenue beat(16)0.96%
PT rev (1m)0%
PT rev (3m)-0.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.47%
EPS NY rev (1m)0%
EPS NY rev (3m)-47.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 250.14 | ||
| Fwd PE | 71.36 | ||
| P/S | 2.16 | ||
| P/FCF | 51.83 | ||
| P/OCF | 15.69 | ||
| P/B | 4.5 | ||
| P/tB | 40.02 | ||
| EV/EBITDA | 15.41 |
EPS(TTM)0.21
EY0.4%
EPS(NY)0.74
Fwd EY1.4%
FCF(TTM)1.01
FCFY1.93%
OCF(TTM)3.35
OCFY6.37%
SpS24.31
BVpS11.68
TBVpS1.31
PEG (NY)N/A
PEG (5Y)14.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.97% | ||
| ROE | -3.6% | ||
| ROCE | 2.9% | ||
| ROIC | 2.38% | ||
| ROICexc | 3.19% | ||
| ROICexgc | 5.13% | ||
| OM | 4.38% | ||
| PM (TTM) | N/A | ||
| GM | 22.61% | ||
| FCFM | 4.17% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
ROICexc(3y)3.61%
ROICexc(5y)3.42%
ROICexgc(3y)6.03%
ROICexgc(5y)5.63%
ROCE(3y)3.6%
ROCE(5y)3.56%
ROICexcg growth 3Y-3.51%
ROICexcg growth 5Y-1.27%
ROICexc growth 3Y-4.28%
ROICexc growth 5Y-1.4%
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.1 | ||
| Debt/FCF | 12.96 | ||
| Debt/EBITDA | 3.48 | ||
| Cap/Depr | 89.2% | ||
| Cap/Sales | 9.6% | ||
| Interest Coverage | 0.97 | ||
| Cash Conversion | 90.9% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.01 | ||
| Quick Ratio | 2.01 | ||
| Altman-Z | 1.78 |
F-Score5
WACC9.31%
ROIC/WACC0.26
Cap/Depr(3y)97.03%
Cap/Depr(5y)109.5%
Cap/Sales(3y)9.85%
Cap/Sales(5y)9.84%
Profit Quality(3y)1105%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.69%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%-600%
EPS Next Y-62.53%
EPS Next 2Y8.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.76%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%9.19%
Revenue Next Year7.99%
Revenue Next 2Y8.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.09%
EBIT growth 3Y5.38%
EBIT growth 5Y8.53%
EBIT Next Year110.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.28%
FCF growth 3Y90.52%
FCF growth 5Y8.35%
OCF growth 1Y44.54%
OCF growth 3Y15.95%
OCF growth 5Y17.44%